Search Results - "Liu, Shangqin"

Refine Results
  1. 1

    Spatial Downscaling of NPP-VIIRS Nighttime Light Data Using Multiscale Geographically Weighted Regression and Multi-Source Variables by Liu, Shangqin, Zhao, Xizhi, Zhang, Fuhao, Qiu, Agen, Chen, Liujia, Huang, Jing, Chen, Song, Zhang, Shu

    Published in Remote sensing (Basel, Switzerland) (01-12-2022)
    “…Remote sensing images of nighttime lights (NTL) were successfully used at global and regional scales for various applications, including studies on population,…”
    Get full text
    Journal Article
  2. 2

    Megakaryocyte aplastic thrombocytopenia after CAR T-cell therapy in a patient with multiple myeloma: A case report by Liu, Shangqin, Gui, Chengsi

    Published in Oncology and translational medicine (01-02-2021)
    “…Abstract Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment strategy for hematologic malignancies. The success of CAR T-cell therapy…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Multi-Scale Massive Points Fast Clustering Based on Hierarchical Density Spanning Tree by Chen, Song, Zhang, Fuhao, Zhang, Zhiran, Yu, Siyi, Qiu, Agen, Liu, Shangqin, Zhao, Xizhi

    “…Spatial clustering is dependent on spatial scales. With the widespread use of web maps, a fast clustering method for multi-scale spatial elements has become a…”
    Get full text
    Journal Article
  5. 5

    A rare face of follicular lymphoma: reverse variant of follicular lymphoma by Maskey, Ninu, Chen, Qiongrong, Liu, Fang, Liu, Shangqin, Tian, Sufang

    Published in Diagnostic pathology (03-04-2020)
    “…Reverse Variant of Follicular Lymphoma (RVFL) is one of the rare morphological variants of FL, characterized by dark staining small centrocytes in the center…”
    Get full text
    Journal Article
  6. 6

    Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells by Chang, Pei-Ching, Wang, Tao-Yeuan, Chang, Yi-Ting, Chu, Cheng-Ying, Lee, Chin-Ling, Hsu, Hung-Wei, Zhou, Tyng-An, Wu, Zhaoju, Kim, Randie H, Desai, Sonal J, Liu, Shangqin, Kung, Hsing-Jien

    Published in PloS one (14-02-2014)
    “…Prostate cancer (PCa) cells undergoing neuroendocrine differentiation (NED) are clinically relevant to the development of relapsed castration-resistant PCa…”
    Get full text
    Journal Article
  7. 7

    Association between diabetes mellitus, hypertension, hyperlipidemia, chronic viral hepatitis, and the risk of multiple myeloma: a case-control study by Zhou, Gang, Meng, Xiangyu, Liu, Shangqin

    Published in Oncology and translational medicine (01-04-2020)
    “…Abstract Objective This case-control study aimed to investigate whether diabetes mellitus (DM), hypertension, hyperlipidemia, and chronic viral hepatitis are…”
    Get full text
    Journal Article
  8. 8

    Puerarin-induced immune hemolytic anemia by Chen, Fei, Liu, Shangqin, Wu, Jiang

    Published in International journal of hematology (01-07-2013)
    “…Drug-induced immune hemolytic anemia (DIIHA) is a relatively uncommon condition characterized by a sudden drop in hemoglobin, putatively following exposure to…”
    Get full text
    Journal Article
  9. 9

    Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation by Lu, Bin, Sun, Xueqin, Chen, Yuxuan, Jin, Qi, Liang, Qin, Liu, Shangqin, Li, Yamu, Zhou, Yan, Li, Wenxin, Huang, Zan

    “…INTRODUCTION: Altered gene expression coincides with leukemia development and may affect distinct features of leukemic cells. PITHD1 was significantly…”
    Get full text
    Journal Article
  10. 10

    PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway by Yan, Hongzhu, Sun, Yanling, Wu, Qian, Wu, Zhe, Hu, Meichun, Sun, Yuanpeng, Liu, Yusi, Ma, Zi, Liu, Shangqin, Xiao, Wuhan, Liu, Fuxing, Ning, Zhifeng

    Published in Frontiers in oncology (13-02-2020)
    “…Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1), a co-activator of estrogen receptors alpha, was confirmed to be directly associated with the…”
    Get full text
    Journal Article
  11. 11

    Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells by Liu, Shangqin, Ma, Zi, Cai, Huili, Li, Qian, Rong, Wenyu, Kawano, Michio

    Published in European journal of haematology (01-02-2010)
    “…Interleukin‐6 (IL‐6) is an important growth factor for myeloma cells. IL‐6 promotes the survival and proliferation of multiple myeloma (MM) cells through the…”
    Get full text
    Journal Article
  12. 12

    Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells by Ma, Zi, Otsuyama, Ken-ichiro, Liu, Shangqin, Abroun, Saeid, Ishikawa, Hideaki, Tsuyama, Naohiro, Obata, Masanori, Li, Fu-Jun, Zheng, Xu, Maki, Yasuko, Miyamoto, Koji, Kawano, Michio M.

    Published in Blood (15-04-2005)
    “…In the search for a more effective adjuvant therapy to treat multiple myeloma (MM), we investigated the effects of the traditional Chinese herbal medicines…”
    Get full text
    Journal Article
  13. 13

    Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals by ISHIKAWA, Hideaki, TSUYAMA, Naohiro, OBATA, Masanori, KAWANO, Michio M, SHANGQIN LIU, ABROUN, Saeid, LI, Fu-Jun, OTSUYAMA, Ken-Ichiro, XU ZHENG, ZI MA, MAKI, Yasuko, IQBAL, Mohd S

    Published in Oncogene (15-09-2005)
    “…Interleukin-6 (IL-6) is a cytokine that regulates the proliferation of some tumor cells including multiple myeloma (MM). Ectopic expression of fibroblast…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6 by SHANGQIN LIU, OTSUYAMA, Ken-Ichiro, ZI MA, ABROUN, Saeid, SHAMSASENJAN, Karim, AMIN, Jakia, ASAOKU, Hideki, KAWANO, Michio M

    Published in International journal of hematology (01-01-2007)
    “…Human primary myeloma cells are well known to be heterogeneous with regard to morphology and surface phenotype. We confirmed the heterogeneous expression of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma by Li, Fu-Jun, Tsuyama, Naohiro, Ishikawa, Hideaki, Obata, Masanori, Abroun, Saeid, Liu, Shangqin, Otsuyama, Ken-ichiro, Zheng, Xu, Ma, Zi, Maki, Yasuko, Kawano, Michio M.

    Published in Blood (15-04-2005)
    “…CD45, a receptor-type tyrosine phosphatase, is required for interleukin-6 (IL-6)-induced proliferation in human myeloma cells, which express the shortest…”
    Get full text
    Journal Article
  18. 18

    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk by Inoue, Kosuke, Nishikawa, Tetsuo, Liu, Li, Chen, Yajun, Liu, Shangqin, Ioannou, Adam, Ma, Yuan, Cook, Nancy R., Hu, Frank B.

    Published in The New England journal of medicine (02-06-2022)
    “…To the Editor: Using pooled data from six prospective cohort studies, Ma et al. (Jan. 20 issue) 1 found an association of higher sodium excretion and lower…”
    Get full text
    Journal Article
  19. 19

    Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation by Ishikawa, Hideaki, Tsuyama, Naohiro, Abroun, Saeid, Liu, Shangqin, Li, Fu-Jun, Otsuyama, Ken-Ichiro, Zheng, Xu, Kawano, Michio M

    Published in Leukemia & lymphoma (01-09-2003)
    “…Multiple myeloma (MM) is a proliferative disorder of monoclonal plasma cells which accumulate in human bone marrow, and myeloma cells proliferate in response…”
    Get full text
    Journal Article
  20. 20

    Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling by Liu, Xiaoping, Liu, Shengcai, Chen, Jiarui, He, Li, Meng, Xiangyu, Liu, Shangqin

    Published in Annals of hematology (01-10-2016)
    “…Although the response rates of chemotherapy in patients with acute T-lymphoblastic leukemia (T-ALL) have improved significantly, the outcome of these patients…”
    Get full text
    Journal Article